C8750, C8760, C8770, C8780, C8790 For Research Use Only. Not for Use in Diagnostic Procedures.
Patents - Disclaimers
C8750, C8760, C8770, C8780, C8790 This product is sold solely for use for research purposes in fields other than plants. This product is not transferable. If the purchaser is not willing to accept the conditions of this label license, Promega is willing to accept the return of the product and provide the purchaser with a full refund. However if the product is used, then the purchaser agrees to be bound by the conditions of this limited use statement. This product is sold by Promega Corporation under license from Benitec Australia Ltd and CSIRO as co-owners of U.S. Pat. No. 6,573,099 and foreign counterparts. For information regarding licenses to these patents for use of ddRNAi as a therapeutic agent or as a method to treat/prevent human disease, please contact Benitec at firstname.lastname@example.org. For the use of ddRNAi in other fields, please contact CSIRO at: www.pi.csiro.au/RNAi.
C8790 BY USE OF THIS PRODUCT, RESEARCHER AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE STATEMENT. If the researcher is not willing to accept the conditions of this limited use statement, and the product is unused, Promega will accept return of the unused product and provide the researcher with a full refund.
Researchers may use this product for research use only, no commercial use is allowed. Commercial Use means any and all uses of this product and derivatives by a party for monetary or other consideration and may include but is not limited to use in: (1) product manufacture; and (2) to provide a service, information or data; and/or resale of the product or its derivatives, whether or not such product or derivatives are resold for use in research. Researchers shall have no right to modify or otherwise create variations of the nucleotide sequence of the Monster Green® gene except that researchers may create fused gene sequences provided that the coding sequence of the resulting Monster Green® gene has no more than four deoxynucleotides missing at the affected terminus compared to the intact Monster Green® gene sequence. No other use or transfer of this product or derivatives is authorized without the prior express, written consent of Promega Corporation. Researchers may transfer derivatives to others for research use provided that at the time of transfer a copy of this label license is given to the recipients and recipients agree to be bound by the terms of this label license. PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING FOR MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE WITH REGARDS TO THE PRODUCT. The terms of this agreement shall be governed under the laws of the State of Wisconsin, USA.
C8750, C8760, C8770, C8780 Patent Pending.
C8750, C8760, C8770, C8780, C8790 This product is covered under license from Carnegie Institution of Washington under U.S. Pat. Nos. 6,506,559, 7,538,095, 7,560,438, Australian Pat. No. 743798 and other patents pending. Commercial use of this product will require a separate license from Carnegie.
C8790 Certain applications of this product may require licenses from others.
C8790 The gene encoding Monster Green® Fluorescent Protein is exclusively licensed to Promega Corporation under U.S. Pat. Nos. 7,291,711 and 7,413,874 and other patents pending.